Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.

Clinical trial NCT02072616 · TERMINATED

Trial details

NCT number: NCT02072616
Sponsor: University Hospital, Rouen
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Circulating Tumor Cells Pancreatic Adenocarcinoma Circulating Tumor DNA (KRAS)CA 19.9

Start date: 2014-09-16
Primary completion: 2022-02-28
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.